Medical devices and methods for regulating the tissue response to vascular closure devices
CA 2529754 C · Owner: Iyer, Sriram · Inventors: Kipshidze, Nicholas; Roubin, Gary; Nikolaychik, Victor
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Devices and methods for reducing, eliminating,preventing suppressing, or , treating tissue responses to hemostatic devices e.g. biological sealants or vascular procedures are disclosed. The invention employs a combination of resorbable, biocompatible matrix materials and a variety of therapeutic agents, such as antiproliferatives or antibiotics applied to a vascular , puncture or incision to achieve hemostasis following diagnostic or interventional vascular catheterizations and to treat neointimal hyperplasia and stenosis . A matrix of a material such as collagen provides a reservoir of a therapeutic agent such as rapamycin (sirolimus) and its derivatives and analogs for delivery at …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 18, 2004 and granted May 10, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 18, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 18, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.